Mofuder (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mofuder, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory and allergic skin conditions such as atopic dermatitis, psoriasis, contact dermatitis, and seborrheic dermatitis in patients requiring prescription therapy.

GNH USA supplies Mofuder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers can rely on consistent product availability and regulatory compliance across markets.

Mofuder (mometasone furoate) is used to manage inflammatory skin disorders by reducing inflammation and immune response. - Atopic dermatitis: alleviates redness, itching and scaling. - Psoriasis: decreases plaque formation and erythema. - Contact dermatitis: reduces irritation and swelling caused by allergens. - Seborrheic dermatitis: controls flaking and redness on scalp and face. - Other inflammatory skin disorders: provides anti‑inflammatory relief for various dermatitis types.

Topical application of Mofuder may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus. - Dryness or peeling of the skin. - Erythema. - Folliculitis. - Acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia. - Hypopigmentation. - Secondary infection (bacterial, fungal, viral). - Systemic corticosteroid effects (e.g., adrenal suppression) with extensive use. - Allergic contact dermatitis.

Before prescribing Mofuder, clinicians should consider several safety measures. - Assess severity: use only for moderate to severe inflammatory skin conditions where benefits outweigh risks. - Duration of therapy: limit continuous use to the shortest period necessary, typically not exceeding 2‑4 weeks for most areas. - Application area: avoid use on large body surface areas, broken skin, or mucous membranes. - Pediatric use: exercise caution in children; monitor for growth suppression with prolonged therapy. - Concomitant steroids: avoid simultaneous use of other potent topical corticosteroids on the same site. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Mofuder can interact with other medications that affect corticosteroid metabolism or skin integrity.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic side effects. - CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug levels, enhancing adverse effects. - Antifungal or antibacterial agents applied to the same area: may increase irritation.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclosporine): monitor for heightened infection risk. - Phototherapy: may increase skin sensitivity; adjust treatment schedule. - Non‑steroidal anti‑inflammatory drugs (topical): observe for additive irritation.